Stock screener

BLFS

Conviction 82HealthcareScan · Fri, Jun 26, 2026
BLFS$28.66+4.20%
ResistanceSupportVol 14Insider sell
63 bars
4
4
4
Vol MA14 985.04K
Mar 27Apr 15May 4May 20Jun 9Jun 26
BIOLIFE SOLUTIONS INCELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUSwww.biolifesolutions.com
Price28.66
Change+4.20%
Gap-0.44%
Rel volume3.97×
Avg volume967.77K
Avg $ vol25.95M
SMA 2026.46
SMA 5023.88
SMA 20023.98
Price vs 50+20.01%
Price vs 200+19.48%
MA stackmixed
50/200 cross
Supertrendup · 23.99
RSI (14)66
MACD hist-0.03
MACD crossbear · 9d
Stoch %K / %D78 / 62
ADX (14)32
+DI / −DI33 / 12
RSI divergence
MACD divergence
ATR %+5.02%
ADR %5.43%
52w high28.79
52w low18.15
From 52w high-0.47%
Above 52w low+57.88%
New 52w highYes
SqueezeOff
Bollinger width14.72%
%B1.06
Donchian pos78.65%
Donchian high29.78
Donchian low24.51
AVWAP (52w high)28.58
vs AVWAP high+0.27%
AVWAP (52w low)23.83
vs AVWAP low+20.26%
OBV trendUp
Chaikin MF (20)-0.09
Today vs 20d3.97×
Avg vol (14d)985.04K
Avg vol (20d)967.77K
Avg $ vol (20d)25.95M
Market cap
RS 3m (vs SPY)+26.67%
RS 6m (vs SPY)+0.75%
RS line new highYes
Trend template6/8
Technical rank83.5
1 week+10.04%
1 month+16.96%
3 months+45.83%
6 months+12.55%
1 year+34.09%
YTD+19.95%
P/E-292.35
P/B3.61
P/S216.99
P/FCF126.29
EPS-0.1000
Div yield
ROE-1.23%
ROA-1.15%
Debt/Eq0.01
Current7.30
EV/EBITDA-92.20
Gross margin
Net margin-74.22%
Rev growth-30.83%
EPS growth77.23%
Price target33.00
Target upside20.02%
Analyst ratingBuy
Institutional108.86%
Ent. value1.32B
Revenue1.24M
Net income1.19M
Gross profit17.5M
Free cash flow10.64M
IndustryELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
ExchangeNasdaq
Shares out48.86M
Employees155
ListedWed, Nov 22, 1989
Free float
Float %
Short interest
Days to cover
Short volume
Squeeze score
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeA
Conviction82 / 100
Pattern quality
Tech rank83.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance28.08
Support20.46
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BLFS

All disclosures →
No recent disclosed trades by Congress in BLFS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BLFS · 10 sells

InsiderSideShares
Werner Sean
Chief Technology Officer · Common Stock · 2026-06-18
Tax420
Mathew Aby J.
EVP & Chief Scientific Officer · Common Stock · 2026-06-18
Tax564
Wichterman Troy
Chief Financial Officer · Common Stock · 2026-06-18
Tax937
DE GREEF RODERICK
President and CEO · Common Stock · 2026-06-18
Tax2.77K
Berard Todd
Chief Marketing Officer · Common Stock · 2026-06-18
Tax470
Mathew Aby J.
EVP & Chief Scientific Officer · Common Stock · 2026-06-08
Tax627
Berard Todd
Chief Marketing Officer · Common Stock · 2026-06-08
Tax356
Wichterman Troy
Chief Financial Officer · Common Stock · 2026-06-08
Tax1.03K
Casdin Eli
10% owner · Common Stock, par value $0.001 per share · 2026-05-21
Sell650K
Casdin Partners Master Fund, L.P.
10% owner · Common Stock, par value $0.001 per share · 2026-05-21
Sell650K

SEC filings

EDGAR filings in BLFS · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.